We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6728:TSEULVAC, Inc. Analysis

Data as of 2026-03-15 - not real-time

¥9,138.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ULVAC, Inc. is trading at ¥9,138, comfortably above its 20‑day SMA of ¥10,041 but still above the 50‑day SMA of ¥8,873, indicating a short‑term pull‑back within a broader bullish framework. The RSI of 44.5 suggests neutral momentum, while the MACD histogram remains negative (‑208), flagging lingering bearish pressure. Volume is on a decreasing trend and 30‑day volatility is high at 66%, which together heighten the risk of near‑term price swings. The DCF‑derived fair value of ¥6,767 places the current price in the overvalued zone, yielding an upside/downside estimate of roughly –8.7% relative to intrinsic value.
Fundamentally, the company posted a modest revenue decline of 3.6% yet maintains a solid gross margin of 30.5% and an operating margin near 8.7%. Cash reserves are robust (¥100.2 bn) against a modest debt load (¥43.5 bn, debt‑to‑equity 18.7%), supporting a dividend yield of 1.79% with a payout ratio under 50%. Analyst sentiment is strongly positive ("strong_buy"), with median target prices around ¥10,400, implying potential upside if valuation pressures ease and the sector demand for vacuum‑based technologies continues to expand.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at ¥8,775 with bearish MACD histogram
  • High 30‑day volatility and decreasing volume
  • Current valuation above DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong analyst consensus and median target price of ¥10,400
  • Solid cash position and sustainable dividend yield
  • Industry tailwinds in display, battery and semiconductor vacuum applications

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable earnings margins and low debt‑to‑equity ratio
  • Potential mean‑reversion toward DCF fair value
  • Long‑term demand for specialty industrial vacuum equipment

Key Metrics & Analysis

Financial Health

Revenue Growth-3.60%
Profit Margin5.19%
P/E Ratio27.0
ROE6.01%
ROA3.20%
Debt/Equity18.69
P/B Ratio2.0
Op. Cash Flow¥33.7B
Free Cash Flow¥20.4B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI44.5
Support¥8,775.00
Resistance¥11,090.00
MA 20¥10,041.55
MA 50¥8,872.88
MA 200¥6,763.93
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value¥6,767.07
Target Price¥9,937.50
Upside/Downside8.75%
GradeOvervalued
TypeValue
Dividend Yield1.79%

Risk Assessment

Beta0.81
Volatility66.11%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.